Pharmafile - Research and Development News
MSD Keytruda has enjoyed the most success of the PD-1/L1 therapies in clinical trials recently and it’s rapidly cementing its position as the leader...
The joint partnership between Vifor Pharma and Fresenius Medical Care, Vifor Fresenius, has put down $50 in upfront cash and an equity investment of...
Sun Pharma's Yonsa has been awarded FDA approval in combination with methylprednisolone for the treatment of metastatic castration-resistant...
The latest global research paints a bleak picture of future global public health, predicting that almost a quarter of the entire global population...
The FDA is doubling down on the rise of kratom by targeting three marketers and distributors of such products.
Much has already been written about Takeda and its massive financial stretch to pull in the Shire acquisition, in the massive $62 billion deal. It’s...
A first-of-its-kind collaboration has been announced by the governments of India, Sweden and The Netherlands with the goal of advancing research in...
Professor Mel Greaves, of The Institute of Cancer Research, has spent 30 years uncovering what is behind the mysterious rise in rates of acute...
The EMA has judged that the benefits offered by Zinbryta do not outweigh its risks, following a review carried out by the agency’s Pharmacovigilance...
Hemlibra was widely expected to become the dominant therapeutic for treating haemophilia patients and its latest clinical trial results only cements...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches
